Philippines Health News API

{
    "totalArticles": 105588,
    "articles": [
        {
            "id": "a79db0b31343bfed58f6c98a9e59470c",
            "title": "Cadiz mayor orders close monitoring after ‘Aloy’ fish triggers mass allergies",
            "description": "Aloy must be kept fresh to prevent histamine poisoning.* Mayor Salvador Escalante Jr. confirmed that local health officials are closely monitoring residents after approximately 15 people suffered a…",
            "content": "Mayor Salvador Escalante Jr. confirmed that local health officials are closely monitoring residents after approximately 15 people suffered allergic reactions from consuming Aloy (also known as Tulingan) in Cadiz City, Negros Occidental, on Monday, Ma... [1258 chars]",
            "url": "https://digicastnegros.com/mayor-says-cadiz-residents-suffer-allergies-after-eating-aloy-fish-close-monitoring-on/",
            "image": "https://i0.wp.com/digicastnegros.com/wp-content/uploads/2026/04/image-6.png?fit=553%2C367&ssl=1",
            "publishedAt": "2026-04-06T14:56:44Z",
            "lang": "en",
            "source": {
                "id": "1af09b166990b2a3de7620eab9dd6f29",
                "name": "digicastnegros.com",
                "url": "https://digicastnegros.com"
            }
        },
        {
            "id": "8cef229993c4410a6bdeee2bad3d597c",
            "title": "Azurity Pharmaceuticals Announces the Availability of ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution, CII",
            "description": "Woburn, MA, April 06, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced that ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution is now available in the United States for treating ADHD in adults and pediatric patients 6 years and older. Arynta, a ready-to-use lisdexamfetamine oral solution that may be stored at room temperature between 68°F to 77°F (20°C to 25°C),1 received FDA approval in June 2025.",
            "content": "Woburn, MA, April 06, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced that ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution is now available in the United States for treating ADHD in adults and pediatric patients 6 years and older... [12454 chars]",
            "url": "https://www.manilatimes.net/2026/04/06/tmt-newswire/globenewswire/azurity-pharmaceuticals-announces-the-availability-of-arynta-lisdexamfetamine-dimesylate-oral-solution-cii/2314829",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/04/06/1002488.jpg",
            "publishedAt": "2026-04-06T13:33:15Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        },
        {
            "id": "27deb36fcb5d7fa6b4b36a5e4ce0cb9d",
            "title": "Advancing access and early action in women’s cancer care",
            "description": "WOMEN’S cancers — such as breast, cervical and endometrial cancer — continue to pose a significant health challenge in the Philippines not only because of the disease itself but due to gaps in early detection, awareness, and access to timely treatment. Across patient experiences, medical insights, and policy perspectives, a clear direction is emerging — Improving outcomes for women requires stronger systems that enable prevention, early diagnosis, and access to the right care.",
            "content": "WOMEN’S cancers — such as breast, cervical and endometrial cancer — continue to pose a significant health challenge in the Philippines not only because of the disease itself but due to gaps in early detection, awareness, and access to timely treatmen... [2530 chars]",
            "url": "https://www.manilatimes.net/2026/04/06/tmt-newswire/advancing-access-and-early-action-in-womens-cancer-care/2314821",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/04/06/1002481.jpg",
            "publishedAt": "2026-04-06T13:23:00Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        }
    ]
}